DBV Technologies | DBVT - درآمد حاصل از بهره





درآمد حاصل از بهره تغییر دادن تاریخ
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Amarin USD 3.37M 3.37M 2024-12
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
DBV Technologies USD -0.32 0.02 2024-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Galectin Therapeutics USD -2.71M 2.77M 2023-12
Incyte USD 30.75M 3.97M 2025-12
Insmed USD 765K 55K 2024-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09